Invention Grant
- Patent Title: KRas G12C inhibitors
-
Application No.: US16595666Application Date: 2019-10-08
-
Publication No.: US10968214B2Publication Date: 2021-04-06
- Inventor: David Anthony Barda , David Andrew Coates , Ryan James Linder , Sheng-Bin Peng , Mohammad Sadegh Zia-Ebrahimi
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Cedric A. D'Hue
- Main IPC: C07D239/72
- IPC: C07D239/72 ; A61K31/517 ; A61P35/00 ; C07D417/14 ; C07K16/28
Abstract:
The present invention provides compounds of the Formula I below where R1, R2 and m are as described herein, pharmaceutically acceptable salts of the compounds of Formula 1, and methods of using these compounds and salts for treating patients for cancer.
Information query
